Cryo-Cell International Inc (CCEL) SEC filings

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30

Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30

$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

SEC filings

40 of Cryo-Cell International's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	8-K	Oct 27, 2026	Oct 28, 2026	SEC EDGAR
Proxy statement	DEF 14A	Oct 27, 2026	Oct 13, 2026	SEC EDGAR
Quarterly report	10-Q	Aug 31, 2026	Oct 9, 2026	SEC EDGAR
Current report	8-K	Sep 10, 2026	Sep 14, 2026	SEC EDGAR
Quarterly report	10-Q	May 31, 2026	Jul 15, 2026	SEC EDGAR
Current report	8-K	May 6, 2026	May 8, 2026	SEC EDGAR
Quarterly report	10-Q	Feb 28, 2026	Apr 14, 2026	SEC EDGAR
Current report	8-K	Mar 9, 2026	Mar 12, 2026	SEC EDGAR
Annual report	10-K	Nov 30, 2025	Feb 27, 2026	SEC EDGAR
Current report	8-K	Nov 12, 2025	Nov 12, 2025	SEC EDGAR
Current report	8-K	Oct 18, 2025	Oct 23, 2025	SEC EDGAR
Quarterly report	10-Q	Aug 31, 2025	Oct 15, 2025	SEC EDGAR
Proxy statement	DEF 14A	Oct 21, 2025	Sep 26, 2025	SEC EDGAR
Current report	8-K	Sep 8, 2025	Sep 10, 2025	SEC EDGAR
Quarterly report	10-Q	May 31, 2025	Jul 15, 2025	SEC EDGAR
Current report	8-K	May 17, 2025	May 22, 2025	SEC EDGAR
Current report	8-K	May 8, 2025	May 8, 2025	SEC EDGAR
Quarterly report	10-Q	Feb 28, 2025	Apr 14, 2025	SEC EDGAR
Annual report	10-K	Nov 30, 2024	Feb 28, 2025	SEC EDGAR
Current report	8-K	Oct 29, 2024	Oct 31, 2024	SEC EDGAR
Current report	8-K	Oct 29, 2024	Oct 30, 2024	SEC EDGAR
Quarterly report, amended	10-Q/A	Aug 31, 2024	Oct 17, 2024	SEC EDGAR
Current report	8-K	Oct 15, 2024	Oct 17, 2024	SEC EDGAR
Quarterly report	10-Q	Aug 31, 2024	Oct 15, 2024	SEC EDGAR
Proxy statement	DEF 14A	Oct 29, 2024	Oct 7, 2024	SEC EDGAR
Current report	8-K	Sep 13, 2024	Sep 17, 2024	SEC EDGAR
Quarterly report	10-Q	May 31, 2024	Jul 15, 2024	SEC EDGAR
Quarterly report	10-Q	Feb 29, 2024	Apr 15, 2024	SEC EDGAR
Current report	8-K	Mar 25, 2024	Mar 26, 2024	SEC EDGAR
Annual report	10-K	Nov 30, 2023	Feb 28, 2024	SEC EDGAR
Quarterly report	10-Q	Aug 31, 2023	Oct 12, 2023	SEC EDGAR
Current report	8-K	Oct 10, 2023	Oct 12, 2023	SEC EDGAR
Proxy statement	DEF 14A	Oct 10, 2023	Sep 14, 2023	SEC EDGAR
Current report	8-K	Aug 24, 2023	Aug 25, 2023	SEC EDGAR
Quarterly report	10-Q	May 31, 2023	Jul 14, 2023	SEC EDGAR
Quarterly report	10-Q	Feb 28, 2023	Apr 21, 2023	SEC EDGAR
Current report	8-K	Mar 3, 2023	Mar 9, 2023	SEC EDGAR
Annual report	10-K	Nov 30, 2022	Feb 28, 2023	SEC EDGAR
Current report	8-K	Dec 23, 2022	Dec 29, 2022	SEC EDGAR
Quarterly report	10-Q	Aug 31, 2022	Oct 18, 2022	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Cryo-Cell International's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CCEL.

Compare: CCEL vs NIVF · CCEL vs MRAI · CCEL vs MCTA · CCEL vs CELU · CCEL vs PFHO

Revenue growth-2.0% · median -17.8%

Gross margin78.5% · median 22.1%

Operating margin0.6% · median -78.4%

Net margin-6.2% · median -98.0%

Company	Revenue	Growth
CCEL	$31.13M	-2.0%
CELU	$18.67M	-58.1%
MRAI	$17.02M	-17.8%
PFHO	$6.37M	-5.8%
NIVF	–	–
MCTA	–	–

Company

Exchange: NYSE
Industry: Services-Misc Health & Allied Services, NEC
Fiscal year ends: November 30
Employees: 72
Held by institutions: 6.9%
Auditor: Wipfli LLP
SEC CIK: 862692

Advertisement
300 × 250

See a number that looks wrong?